반응식
[NH:1]1[C:9]2[CH:8]=[CH:7][CH:6]=[C:5]([O:10][CH2:11][CH:12]3[O:14][CH2:13]3)[C:4]=2[CH:3]=[CH:2]1.[NH:15]1[C:19]2[CH:20]=[CH:21][CH:22]=[C:23]([N:24]3[CH2:29][CH2:28][NH:27][CH2:26][CH2:25]3)[C:18]=2[N:17]=[CH:16]1>>[NH:1]1[C:9]2[C:4](=[C:5]([O:10][CH2:11][CH:12]([OH:14])[CH2:13][N:27]3[CH2:28][CH2:29][N:24]([C:23]4[C:18]5[N:17]=[CH:16][NH:15][C:19]=5[CH:20]=[CH:21][CH:22]=4)[CH2:25][CH2:26]3)[CH:6]=[CH:7][CH:8]=2)[CH:3]=[CH:2]1참가 물질
3
실험 절차
The title compound is prepared from the reaction of 1-(indole-4-oxy)-2,3-epoxypropane (2.0 mmole) and 1-(1H-benzimidazole-4-yl)piperazine (2 mmole) according to the above procedures.
출처 및 근거
- ORD 기록
- ord-af2a87630a76439fb0042ad8f4483bf7
- 출처 데이터셋
- uspto-grants-2004_02
- 특허 번호
- US06689792B2
연결된 노트
불러오는 중…